Shane Alden Campbell

CIK: 0002068522

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (22.2%)

Derivative conversions

Awards (A)5 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

WST

WEST PHARMACEUTICAL SERVICES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

WST
WEST PHARMACEUTICAL SERVICES INC
May 12, 2026
Exercise(M)
Direct
296 shares-
WST
WEST PHARMACEUTICAL SERVICES INC
May 12, 2026
Tax Payment(F)
Direct
84 shares at avg. $312.07$26K
WST
WEST PHARMACEUTICAL SERVICES INC
May 12, 2026
Exercise(M)
Direct
474 shares-
WST
WEST PHARMACEUTICAL SERVICES INC
May 12, 2026
Tax Payment(F)
Direct
135 shares at avg. $312.07$42K
WST
WEST PHARMACEUTICAL SERVICES INC
Mar 1, 2026
Award(A)
Stock Option (Right to Buy)
Direct
2.7K shares-
WST
WEST PHARMACEUTICAL SERVICES INC
Mar 1, 2026
Award(A)
Rst. Stock Unit
Direct
1.1K shares-
WST
WEST PHARMACEUTICAL SERVICES INC
May 12, 2025
Award(A)
Stock Options (Right to Buy)
Direct
2.9K shares at avg. $219.46-
WST
WEST PHARMACEUTICAL SERVICES INC
May 12, 2025
Award(A)
Rst. Stock Unit
Direct
1.9K shares-
WST
WEST PHARMACEUTICAL SERVICES INC
May 12, 2025
Award(A)
Rst. Stock Unit
Direct
1.2K shares-

		Type	Shares	Price		Ownership
May 12, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Exercise(M)	296	-	$0	Direct
May 12, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Tax Payment(F)	84	$312.07	$26,317	Direct
May 12, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Exercise(M)	474	-	$0	Direct
May 12, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Tax Payment(F)	135	$312.07	$42,107	Direct
Mar 1, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Stock Option (Right to Buy)	2,691	-	-	Direct
Mar 1, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Rst. Stock Unit	1,131	-	-	Direct
May 12, 2025	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Stock Options (Right to Buy)	2,852	$219.46	-	Direct
May 12, 2025	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Rst. Stock Unit	1,891	-	-	Direct
May 12, 2025	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Rst. Stock Unit	1,182	-	-	Direct

1-9 of 9 transactions

About Campbell Shane Alden

Campbell Shane Alden (SEC CIK 0002068522) files insider reports with the SEC as SVP, Proprietary Segment of WEST PHARMACEUTICAL SERVICES INC (WST).

Signal8 holds 4 ownership filings by Campbell Shane Alden (1 Form 3, 3 Form 4), filed between May 14, 2025 and May 14, 2026. Those filings report 9 transactions, from May 12, 2025 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Campbell Shane Alden's filings is in EXTON, PA.

Recent filings by Campbell Shane Alden

May 12, 2026: Option exercise of WST shares (Form 4, code M).
May 12, 2026: Tax withholding of WST shares (Form 4, code F).
May 12, 2026: Option exercise of WST shares (Form 4, code M).
May 12, 2026: Tax withholding of WST shares (Form 4, code F).
Mar 1, 2026: Grants or awards of WST derivative securities (2 lines, Form 4, code A).

Other insiders filing for WEST PHARMACEUTICAL SERVICES INC (WST)

HAUGEN JANET BRUTSCHEA, Director
Favorite Annette F, Sr. VP & Chief HR Officer
Lagarde Michel, President and CEO
McMahon Robert W., SVP & Chief Financial Officer
Pucci Paolo, Director
Michels Douglas A, Director

How to read Form 4 transaction codes